European Journal of Pharmacology

Editorial Board
pp. ii-ii(1)

Editorial
pp. 1-1(1)
Author: de Wied D.

Note from the publisher
pp. 3-3(1)

Molecular physiology of P2 receptors in the central nervous system
pp. 5-17(13)
Authors: Illes P.; Alexandre Ribeiro J.

Induction of proteins involved in multidrug resistance (P-glycoprotein, MRP1, MRP2, LRP) and of CYP 3A4 by rifampicin in LLC-PK₁ cells
pp. 19-28(10)
Authors: Magnarin M.; Morelli M.; Rosati A.; Bartoli F.; Candussio L.; Giraldi T.; Decorti G.

Amino acid substitutions from an indispensable disulfide bond affect P2X₂ receptor activation
pp. 29-35(7)
Authors: Nakazawa K.; Ojima H.; Ishii-Nozawa R.; Takeuchi K.; Ohno Y.

Pharmacological profile of YM348, a novel, potent and orally active 5-HT_2C receptor agonist
pp. 37-43(7)
Authors: Kimura Y.; Hatanaka K.-i.; Naitou Y.; Maeno K.; Shimada I.; Koakutsu A.; Wanibuchi F.; Yamaguchi T.

In vivo effects of aripiprazole on cortical and striatal dopaminergic and serotonergic function
pp. 45-53(9)
Authors: Jordan S.; Koprivica V.; Dunn R.; Tottori K.; Kikuchi T.; Altar C.A.

Behavioral mechanisms underlying inhibition of food-maintained responding by the cannabinoid receptor antagonist/inverse agonist SR141716A
pp. 55-63(9)
Authors: De Vry J.; Schreiber R.; Eckel G.; Jentzsch K.R.

Ritanserin counteracts both rat vacuous chewing movements and nigro-striatal tyrosine hydroxylase-immunostaining alterations induced by haloperidol
pp. 65-69(5)
Authors: Marchese G.; Bartholini F.; Ruiu S.; Casti P.; Casu G.L.; Pani L.

Role of Rho-kinase in maintaining airway smooth muscle contractile phenotype
pp. 71-78(8)
Authors: Gosens R.; Schaafsma D.; Meurs H.; Zaagsma J.; Nelemans S.A.

Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-, reduces acute inflammation
pp. 79-93(15)
Authors: Cuzzocrea S.; Pisano B.; Dugo L.; Ianaro A.; Maffia P.; Patel N.S.A.; Di Paola R.; Ialenti A.; Genovese T.; Chatterjee P.K.; Di Rosa M.; Caputi A.P.; Thiemermann C.